Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36709074
2.
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
NPJ Vaccines
; 9(1): 67, 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38553525
3.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37544326
4.
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Nat Med
; 28(5): 1022-1030, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35411076
5.
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Lancet Respir Med
; 9(10): 1111-1120, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33864736
6.
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
PLoS One
; 14(9): e0222178, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31532789
7.
A proof of concept for structure-based vaccine design targeting RSV in humans.
Science
; 365(6452): 505-509, 2019 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31371616
8.
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines.
Ann Surg Oncol
; 15(12): 3538-49, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18923873
9.
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Clin Cancer Res
; 13(21): 6386-95, 2007 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17975151
10.
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
PLoS One
; 13(11): e0206837, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30388160
11.
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
NPJ Vaccines
; 2: 15, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29263871
12.
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
J Clin Oncol
; 22(22): 4474-85, 2004 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15542798
13.
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
J Clin Oncol
; 21(21): 4016-26, 2003 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14581425
14.
Phase 1 study of pandemic H1 DNA vaccine in healthy adults.
PLoS One
; 10(4): e0123969, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25884189
15.
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial.
PLoS One
; 10(5): e0125914, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25950433
16.
Publication practices and attitudes towards evidence-based medicine in central Asia.
Lancet Glob Health
; 1(2): e73-e74, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25104158
17.
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
J Biol Chem
; 281(27): 18763-73, 2006 Jul 07.
Artigo
Inglês
| MEDLINE | ID: mdl-16648140
18.
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients.
Cancer Immunol Immunother
; 54(11): 1095-105, 2005 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-15889250
19.
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.
J Immunol
; 174(11): 6863-71, 2005 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15905528